skip to Main Content

FDA Regulatory Pathways

The development of drugs, biologics, and medical devices follows rigorous paths to ensure safe and effective medicines. We create FDA regulatory engagement strategies and help clients interpret FDA regulations, guidance, and the likely impact of legislation. Interpreting FDA priorities, resources, User Fee Acts, and label and promotion requirements, our experts can help you manage your pipeline.

FDA Releases Final Guidance on Pre-Submission Program for Medical Devices

On Feb. 18, FDA released guidance outlining how an applicant can obtain FDA feedback on a potential or planned medical device submission reviewed by the Center for Devices and Radiological Health (CDRH) and the Center for Biologics Evaluation and Research (CBER), including the Pre-Submission (formerly pre-Investigational Device Exemption (pre-IDE)) program.

Sign up to receive more insights about FDA Regulatory Pathways
Please enter your email address to be notified when new FDA Regulatory Pathways insights are published.

Back To Top